Free provider profile
SOBIA KIRMANI MOE, M.D.
Need more providers like SOBIA KIRMANI MOE?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What SOBIA KIRMANI MOE prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Vraylar
- Trintellix
- Rexulti
- Auvelity
- Fetzima
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
608-293-2759
Fax
608-646-6768
Practice address
6302 ODANA RD 302, MADISON, WI, 53719
- Registry updated
- 2025-08-18
- NPI issued
- 2009-06-19
- RepVector retrieved
- 11/20/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
6302 ODANA RD 302, MADISON, WI, 53719
608-293-2759
2 practice locations listed
Enumerated 2009-06-19
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 practice locations listed — multi-site footprint.
- — Record updated within the last three years.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
3,171
Medicare patients
103
Part D drug cost
$800,311
Brand-name share
20.2%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Vraylar (Cariprazine Hcl) | 181 | $257,437 |
| Rexulti (Brexpiprazole) | 83 | $114,926 |
| Ingrezza (Valbenazine Tosylate) | 13 | $103,240 |
| Trintellix (Vortioxetine Hydrobromide) | 117 | $68,473 |
| Auvelity (Dextromethorphan Hbr/Bupropion) | 53 | $54,234 |
| Lybalvi (Olanzapine/Samidorphan Malate) | 16 | $24,379 |
| Adderall (Dextroamphetamine/Amphetamine) | 23 | $15,282 |
| Fetzima (Levomilnacipran Hcl) | 35 | $14,250 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across WI — which companies pay providers there.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
